Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03322033 · ClinicalTrials.gov registry record · NA
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03322033 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 1 participants.
The verdict
NCT03322033, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this early feasibility study is to investigate the outcome of selected patients with ascending thoracic aortic pathologies including type A aortic dissection, who are suitable for endovascular repair with the Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System (or the Valiant PS-IDE Stent Graft).
Interventions
- DEVICE Valiant PS-IDE Stent Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2021-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03322033
The ClinicalTrials.gov registry entry for NCT03322033 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valiant PS-IDE Stent Graft is the first listed.
NCT03322033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03322033 about?
NCT03322033 is a clinical study titled "Feasibility of Endovascular Repair of Ascending Aortic Pathologies". The purpose of this early feasibility study is to investigate the outcome of selected patients with ascending thoracic aortic pathologies including type A aortic dissection, who are suitable for endovascular repair with the Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery Syste...
What is the current status of trial NCT03322033?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-12-15. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT03322033?
The interventions under investigation include: Valiant PS-IDE Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT03322033?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.